Impaired PP2A activity was further reported as a common event in AML, with 29/37 cases displaying inactivation [24], suggesting that AML sub-types without c-KIT mutations are also likely to exhibit PP2A inhibition. This evidence concerns the gene KIT and acute myeloid leukemia.